查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539760

2024 年病患自控注射器全球市場報告

Patient Controlled Injectors Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

患者自控注射器的市場規模預計在未來幾年將快速成長。 2028年，將以12.8%的複合年成長率成長至73.2億美元。預測期內的成長是由於人口老化、慢性呼吸道疾病盛行率增加、慢性病盛行率增加、癌症發生率增加以及自體免疫疾病盛行率增加而預測的。這段時期的主要趨勢包括技術進步、人工智慧的整合、遠端醫療、遠端監控、攜帶式和穿戴式設備的進步以及對微創手術的重視。

慢性病盛行率的上升是未來幾年推動患者自控注射器市場成長的前景。人口老化、肥胖流行、社會經濟經濟狀況和環境因素等因素導致慢性病增加，這些慢性病往往持續三個月以上，並隨著時間的推移而惡化。患者控制注射器使患者能夠根據治療計劃準確、方便地自行給藥。例如，美國國家生物技術資訊中心 (NCBI) 於 2023 年 1 月報告稱，到 2050 年，50 歲及以上患有一種或多種慢性病的人數將從 2020 年的 7152 萬人增加 99.5%。萬人。因此，慢性病盛行率的增加預計將推動患者自控注射器市場的發展。

該市場的領先公司正在創新和開發即用型注射器等先進產品，以更好地滿足客戶需求。即用型注射器已預先填充並消毒了正確數量的藥物，無需手動準備，並降低了污染和劑量錯誤的風險。例如，2022 年 10 月，Ypsomed AG 宣布推出一款專為 1.5 至 5.5 毫升液體藥物量身定做的新型自動注射器平台。該設備採用符合人體工學、易於使用的設計，可確保注射過程中患者的舒適度，並具有先進的安全機制，可防止針刺傷害。由於它可以適應各種黏度，因此它還可以用於各種治療應用。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球患者自控注射器市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球病患自控注射器市場表現：規模與成長，2018-2023
  • 全球病患控制注射器市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球病患控制注射器市場：按產品、性能和預測，2018-2023、2023-2028、2033
  • 電子穿戴式注射器
  • 機械式穿戴式注射器
  • 點滴幫浦
  • 全球病患控制注射器市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 癌症治療
  • 自體免疫治療
  • 血液疾病的治療
  • 其他
  • 全球病患控制注射器市場：按分銷管道、績效和預測，2018-2023、2023-2028、2033
  • 醫院藥房
  • 零售藥房
  • 通訊藥房

第 7 章 區域/國家分析

  • 全球病患自控注射器市場：按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球病患自控注射器市場：依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 病患控制注射器市場：競爭格局
  • 病患控制注射器市場：公司簡介
    • Medtronic plc
    • Becton Dickinson and Company
    • West Pharmaceutical Services
    • SCHOTT AG
    • Gerresheimer AG

第31章 其他大型創新企業

  • Phillips-Medisize
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Stevanato Group
  • Ypsomed AG
  • Nemera
  • B. Braun Melsungen AG
  • Elcam Medical
  • Owen Mumford
  • Bespak
  • Unilife Corporation
  • Crossject
  • SHL Group
  • AptarGroup Inc.
  • Credence MedSystems
  • Weibel CDS AG

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r19198

Patient-controlled injectors are medical devices designed to empower patients to self-administer medication with precise control over dosage and timing. They are user-friendly, facilitating independent management of treatment, typically in home settings.

The primary types of patient-controlled injectors include electronic wearable injectors, mechanical wearable injectors, and infusion pumps. Electronic versions enable automated and precise medication delivery, often equipped with connectivity features for tracking and monitoring usage. This enhances convenience and provides data-driven insights for patients. These devices find applications in treatments such as cancer, autoimmune disorders, and blood disorders, distributed through hospital pharmacies, retail pharmacies, and mail-order channels.

The patient-controlled injectors market research report is one of a series of new reports from The Business Research Company that provides patient-controlled injectors market statistics, including patient-controlled injectors industry global market size, regional shares, competitors with a patient-controlled injectors market share, detailed patient-controlled injectors market segments, market trends, and opportunities, and any further data you may need to thrive in the patient-controlled injectors industry. This patient-controlled injectors research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient-controlled injectors market size has grown rapidly in recent years. It will grow from $4.01 billion in 2023 to $4.51 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. Historic period growth was driven by the expansion of home healthcare services, healthcare infrastructure development, rising diabetes prevalence, increasing infectious diseases, and growing adoption of personalized medicine.

The patient-controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $7.32 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. Forecast period growth is anticipated due to an aging population, higher incidence of chronic respiratory diseases, increased prevalence of chronic illnesses, rising cancer rates, and growing prevalence of autoimmune disorders. Key trends in this period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advances in portable and wearable devices, and emphasis on minimally invasive procedures.

The rising prevalence of chronic diseases is poised to drive the growth of the patient-controlled injectors market in the coming years. Chronic illnesses, lasting three months or more and often worsening over time, are increasing due to factors such as an aging population, the obesity epidemic, socioeconomic conditions, and environmental factors. Patient-controlled injectors enable individuals to self-administer medications accurately, conveniently, and according to their treatment schedules. For example, the National Center for Biotechnology Information (NCBI) projected in January 2023 that the number of individuals aged 50 and older with one or more chronic conditions will rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases is expected to propel the patient-controlled injectors market forward.

Leading companies in this market are innovating by developing advanced products such as ready-to-use syringes to better meet customer needs. Ready-to-use syringes come prefilled and sterilized with a precise dose of medication, eliminating the need for manual preparation and reducing risks of contamination and dosing errors. For instance, in October 2022, Ypsomed AG introduced a new autoinjector platform tailored for liquid pharmaceuticals ranging from 1.5 to 5.5 ml. This device features ergonomic design for ease of use, ensuring patient comfort during injections, along with advanced safety mechanisms to prevent accidental needle sticks. It provides visual and audible feedback to confirm successful medication delivery and is versatile for various therapeutic applications due to its compatibility with different viscosities.

In April 2023, LTS Lohmann Therapie-Systeme AG expanded its drug delivery portfolio by acquiring the sorrel wearable injection device business from Eitan Medical. This acquisition enhances LTS's capabilities in advanced wearable injection technologies, further solidifying its presence in the patient-controlled injectors market. Eitan Medical Ltd. is an Israel-based company that develops innovative drug delivery devices, including patient-controlled injectors.

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

North America was the largest region in the patient controlled injectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient controlled injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient-controlled injectors market consists of sales of prefilled syringes, auto-injectors, on-body injectors, and needle-free injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Controlled Injectors Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient controlled injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient controlled injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient controlled injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Electronic Wearable Injector; Mechanical Wearable Injector; Infusion Pumps
  • 2) By Application: Cancer Treatment; Auto-Immune Treatment; Blood Disorder Treatment; Other Application
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order Pharmacies
  • Companies Mentioned: Medtronic plc; Becton Dickinson and Company; West Pharmaceutical Services; SCHOTT AG; Gerresheimer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Controlled Injectors Market Characteristics

3. Patient Controlled Injectors Market Trends And Strategies

4. Patient Controlled Injectors Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Patient Controlled Injectors Market Size and Growth

  • 5.1. Global Patient Controlled Injectors Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Patient Controlled Injectors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Patient Controlled Injectors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Patient Controlled Injectors Market Segmentation

  • 6.1. Global Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Electronic Wearable Injector
  • Mechanical Wearable Injector
  • Infusion Pumps
  • 6.2. Global Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Treatment
  • Auto-Immune Treatment
  • Blood Disorder Treatment
  • Other Application
  • 6.3. Global Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

7. Patient Controlled Injectors Market Regional And Country Analysis

  • 7.1. Global Patient Controlled Injectors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Patient Controlled Injectors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Patient Controlled Injectors Market

  • 8.1. Asia-Pacific Patient Controlled Injectors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Patient Controlled Injectors Market

  • 9.1. China Patient Controlled Injectors Market Overview
  • 9.2. China Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Patient Controlled Injectors Market

  • 10.1. India Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Patient Controlled Injectors Market

  • 11.1. Japan Patient Controlled Injectors Market Overview
  • 11.2. Japan Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Patient Controlled Injectors Market

  • 12.1. Australia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Patient Controlled Injectors Market

  • 13.1. Indonesia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Patient Controlled Injectors Market

  • 14.1. South Korea Patient Controlled Injectors Market Overview
  • 14.2. South Korea Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Patient Controlled Injectors Market

  • 15.1. Western Europe Patient Controlled Injectors Market Overview
  • 15.2. Western Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Patient Controlled Injectors Market

  • 16.1. UK Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Patient Controlled Injectors Market

  • 17.1. Germany Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Patient Controlled Injectors Market

  • 18.1. France Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Patient Controlled Injectors Market

  • 19.1. Italy Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Patient Controlled Injectors Market

  • 20.1. Spain Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Patient Controlled Injectors Market

  • 21.1. Eastern Europe Patient Controlled Injectors Market Overview
  • 21.2. Eastern Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Patient Controlled Injectors Market

  • 22.1. Russia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Patient Controlled Injectors Market

  • 23.1. North America Patient Controlled Injectors Market Overview
  • 23.2. North America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Patient Controlled Injectors Market

  • 24.1. USA Patient Controlled Injectors Market Overview
  • 24.2. USA Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Patient Controlled Injectors Market

  • 25.1. Canada Patient Controlled Injectors Market Overview
  • 25.2. Canada Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Patient Controlled Injectors Market

  • 26.1. South America Patient Controlled Injectors Market Overview
  • 26.2. South America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Patient Controlled Injectors Market

  • 27.1. Brazil Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Patient Controlled Injectors Market

  • 28.1. Middle East Patient Controlled Injectors Market Overview
  • 28.2. Middle East Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Patient Controlled Injectors Market

  • 29.1. Africa Patient Controlled Injectors Market Overview
  • 29.2. Africa Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Patient Controlled Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Patient Controlled Injectors Market Competitive Landscape
  • 30.2. Patient Controlled Injectors Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Becton Dickinson and Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. West Pharmaceutical Services
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. SCHOTT AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Gerresheimer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Patient Controlled Injectors Market Other Major And Innovative Companies

  • 31.1. Phillips-Medisize
  • 31.2. Vetter Pharma-Fertigung GmbH & Co. KG
  • 31.3. Stevanato Group
  • 31.4. Ypsomed AG
  • 31.5. Nemera
  • 31.6. B. Braun Melsungen AG
  • 31.7. Elcam Medical
  • 31.8. Owen Mumford
  • 31.9. Bespak
  • 31.10. Unilife Corporation
  • 31.11. Crossject
  • 31.12. SHL Group
  • 31.13. AptarGroup Inc.
  • 31.14. Credence MedSystems
  • 31.15. Weibel CDS AG

32. Global Patient Controlled Injectors Market Competitive Benchmarking

33. Global Patient Controlled Injectors Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Patient Controlled Injectors Market

35. Patient Controlled Injectors Market Future Outlook and Potential Analysis

  • 35.1 Patient Controlled Injectors Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Patient Controlled Injectors Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Patient Controlled Injectors Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer